EVMN
Evommune, Inc.
NYSE · Healthcare · Biotechnology · US
$12.27
+2.25%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.19x
- Debt / assets
- 0.03x
- Debt / EBITDA
- -0.08x
- Net debt / EBITDA
- 0.54x
Liquidity & coverage
- Current ratio
- 11.68x
- Quick ratio
- 11.68x
- Cash ratio
- 11.48x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $186.8M
Cash & dividend
- FCF / debt
- -9.20x
- Cash flow / debt
- -9.14x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026